ID
12725
Beskrivning
High Dose Ara-C (HDAC) and Interleukin-2 (IL-2) for Patients With Acute Myelogenous Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT00136448
Länk
https://clinicaltrials.gov/show/NCT00136448
Nyckelord
Versioner (1)
- 2015-12-11 2015-12-11 - Julian Varghese
Uppladdad den
11 december 2015
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Acute Myelogenous Leukemia NCT00136448
Eligibility Acute Myelogenous Leukemia NCT00136448
- StudyEvent: Eligibility
Beskrivning
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beskrivning
History of an antecedent hematologic malignancy such as myelodysplastic syndromes (mds).
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0376545
Beskrivning
Uncontrolled infection
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0517627
Beskrivning
History of a previous or concomitant malignancy other than non-melanoma skin cancer.
Datatyp
boolean
Alias
- UMLS CUI [1]
- C2735088
- UMLS CUI [2,1]
- C0009488
- UMLS CUI [2,2]
- C0006826
Beskrivning
Evidence of central nervous system (cns) leukemia.
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1332884
Beskrivning
Current use of corticosteroids.
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0001617
Beskrivning
Prior treatment for aml, other than hydroxyurea.
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C0023467
Similar models
Eligibility Acute Myelogenous Leukemia NCT00136448
- StudyEvent: Eligibility
C0201899 (UMLS CUI [2])
C0201850 (UMLS CUI [3])
C0201976 (UMLS CUI [4])
C0009488 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
C0023467 (UMLS CUI [1,2])